[ad_1]
As covid-19 continues to evolve in the US, researchers are now developing a next-line treatment strategy, including a new method that could help reduce the time they spend recovering from the disease.
Even existing drugs are available antivirals, my antibodies, and medicine, scientists in the US and Europe are now focusing on developing the counterfeit antibodies that the virus binds, which can solve its problems.
To develop this new treatment, scientists first had to develop mice that contain the protein angiotensin-converting enzyme 2, or ACE2. These stay on top of the cells and help regulate events such as healing, inflammation, and blood pressure.
Although ACE2 receptors are found in cells throughout the body, they are most common in the lungs, heart, kidneys, and liver-organs of the disease invasion.
To protect real ACE2 recipients, here is how fraud works:
Typically, the proteins secreted on the surface of the virus act as keys to ACE2 receptors, opening the door to infection. But decoys, which are administered intravenously or through the nose as part of the digestive tract, carry a high protein content, which prevents them from being contaminated. After the infection, the treatment can reduce the amount of viruses in the body, which can mean faster recovery for patients.
In another study led by Daniel nodded, a professor of medicine at Northwestern University, mice infected with the virus and found the drug had fewer symptoms compared with untreated animals, which died.
As of today, only one to the hospital trials ACE2 sales are completed in patients with low symptoms. Nevertheless, more and more researchers are supporting the treatment.
Batlle’s team began working on the production of counterfeit proteins in January 2020 after learning of the first US case, and building on the data obtained from China in 2003 SARS-CoV.
“We knew it would be possible for the SARS-CoV-2 recipient to be ACE2, as they have previously been identified as SARS-CoV,” Batlle says.
But applying this knowledge was not easy. Michael Jewett, a professor of medicine at Northwestern University who did not participate in the study, likens the complex process of deception to a very dangerous picture.
“Restoring biodiversity can be difficult,” says Jewett. “It’s like solving a problem and every time you put one piece in, the rest of the text changes.”
Jewett also suggested that in comparison with antibody drugs, counterfeit ones should be cheaper and easier to use. And some experts hope that the illusion may be able to overcome the problems of the past and the changes that are to come.
In another study, using a technique called deep scanning, Erik Procko, a professor of biochemistry at the University of Illinois Urbana-Champaign, was able to see thousands of different ACE2s in one experiment and see what would attract and build the virus. His team then made a mockery of the imitation of those who did very well. The feces do not bind to the cells but float in the fluid between them to transmit the virus before being attached to the actual recipients of ACE2.
Using three switching modes, his team was able to expand the covid-19 integration. They created deceptive sensors that are connected to the virus much stronger than ACE2.
In experimenting with this technique, the Procko team used mouse muscles instead of live animals. “In the case of in vitro vitro, we know that some of the subcutaneous receptors are positive – sometimes a little better, sometimes a little better, but all are stronger – like monoclonal antibodies that are licensed for emergency use. or he is in the hospital for tests, ”says Procko.
The concern was that one of these changes would allow for so-called viral escape and help strengthen the resistance of the virus to the hospital. But because the counterfeit is very similar to the natural environment, says Procko, the virus cannot change naturally because of their actions.
Due to the diversity of architecture and education, access to biological technologies is distributed unevenly around the world. More research – as well as more money – is needed before the drug can be made public. But advances like this in the long run could lead to a cheaper, easier-to-use, easier-to-use product.
“There are signs promising that deceptions that closely resemble the human ACE2 receiver will be useful and effective against these new species,” says Procko. “I wouldn’t be surprised if we could have some of the fraudsters come to the hospital in a few years.”
[ad_2]
Source link
